HbeAg - Globe Thesis - Globe Thesis

Keyword [HbeAg] Result: 181 - 200 \| Page: 10 of 10
181.	Therapeutic Effect Of Entecavir Combined With Cytokine Induced Killer Cells On HBeAg-positive Chronic Hepatitis B
182.	One-year Efficacy Of Peg-interferon Alpha A Sequential Combinated With Nucleoside Drugs Therapy With High Viral Load And E Antigen-positive Of Hepatitis B
183.	Study Of The Influences Of HBsAg Clearance In HBeAg Negative Chronic Hepatitis B Patients
184.	Comparison Of METAVIR Scores From Patients With Chronic Hepatitis B With HbeAg Positive / Negative And Normal Or Mildly Raised Alanine Aminotransferase
185.	Relationship Between Efficacy Of Peg-IFN Therapy And Atg5 Polymorphism And Chinese Medicine Constitution With In Hbeag Positive Patients With Chronic Hepatitis B
186.	Analysis Of Correlation Between IFN-Î»s And Concentrations Of HBV DNA, HBeAg In Patients With Chronic Hepatitis B
187.	The Clinical Observation Of XiaoYao Pill Combined With Cytokine-induced Killer Cell In Treating HBeAg-positive Chronic Hepatitis B Patients With Syndrome Of Stagnation Of Liver Qi With Deficiency Of Spleen
188.	Antivirus/immunomodulatory Therapy In HBeAg Positive And Treatment-naive Patients With Chronic Hepatitis B
189.	Antivirus/Immunomodulatory Therapy Induce CccDNA Decline In Chronic Hepatitis B Patients With HBeAg Positive And Treatment-na(?)ve
190.	Cost-effectiveness Analysis Of Nucleos(t)ide Analogue Monotherapies And Initial Combination Treatment For Chinese HBeAg-positive Chronic Hepatitis B Patients
191.	Study Of Peginterferon Alpha Treatment In 210 HBeAg-PositiveChronic Hepatitis B Patients
192.	Role Of Tfh Cell-mediated Humoral Immune Response In The Process Of HBeAg Seroconversion In CHB Patients Receiving Peginterferon-Î‘lpha Therapy
193.	Efficacy Of Pegylated-interferon In Treatment-experienced Chinese Patients With HBeAg Positive Chronic Hepatitis B
194.	A Modle Effectively Predicts HBeAg Seroconversion Long Term Entecavir Therapy
195.	Changes Of Immune Cells And Its Association With HBV-DNA, HBeAg Tumor Stage In Patients With Primary Hepatocellular Carcinoma
196.	HBV Inhibits LPS-induced NLRP3 Inflammasome Activation And IL-1β Production Via Suppressing NF-κB Pathway And ROS Production
197.	Altered Serum N-Glycomics In HBeAg-Negative CHB And Research On The Effect Of Invigorating Kidney And Eliminate Pathogenic Method On Anti-liver Fibrosis
198.	The Influences Of Dynamic Changes Of T-cell Receptor Repertoires On Antiviral Therapy Outcome In Patients With Chronic Hepatitis B
199.	Serum Markers Expression In Patients With The Low Viral Load Of Hepatitis B Virus
200.	The Efficacy Of Entecavir For The Treatment Of HBeAg-positive And HBeAg-negative, Chronic Hepatitis B And Liver Cirrhosis
<<First <Prev Next> Last>> Jump to